TY - JOUR
T1 - Gene Expression Profiles Define a Key Checkpoint for Type 1 Diabetes in NOD Mice
AU - Eckenrode, Sarah E.
AU - Ruan, Qingguo
AU - Yang, Ping
AU - Zheng, Weipeng
AU - McIndoe, Richard A
AU - She, Jin-Xiong
PY - 2004/2
Y1 - 2004/2
N2 - cDNA microarrays with > 11,000 cDNA clones from an NOD spleen cDNA library were used to identify temporal gene expression changes in NOD mice (1-10 weeks), which spontaneously develop type 1 diabetes, and changes between NOD and NOD congenic mice (NO-D.Idd3/Idd10 and NOD.B10Sn-H2b), which have near zero incidence of insulitis and diabetes. The expression profiles identified two distinct groups of mice corresponding to an immature (1-4 weeks) and mature (6-10 weeks) state. The rapid switch of gene expression occurring, around 5 weeks of age defines a key immunological checkpoint. Sixty-two known genes are upregulated, and 18 are downregulated at this checkpoint in the NOD. The expression profiles are consistent with increased antibody production, antigen presentation, and cell proliferation associated with an active autoimmuneresponse. Seven of these genes map to confirmed diabetes susceptibility regions. Of these seven, three are excellent candidate genes not previously implicated in type 1 diabetes. Ten genes are differentially expressed between the NOD and congenic NOD at the immature stage (Hspa8, Hif1a, and several involved in cellular functions), while the other 70 genes exhibit expression differences during the mature (6-10 week) stage, suggesting that the expression differences of a small number of genes before onset of insulitis determine the disease progression.
AB - cDNA microarrays with > 11,000 cDNA clones from an NOD spleen cDNA library were used to identify temporal gene expression changes in NOD mice (1-10 weeks), which spontaneously develop type 1 diabetes, and changes between NOD and NOD congenic mice (NO-D.Idd3/Idd10 and NOD.B10Sn-H2b), which have near zero incidence of insulitis and diabetes. The expression profiles identified two distinct groups of mice corresponding to an immature (1-4 weeks) and mature (6-10 weeks) state. The rapid switch of gene expression occurring, around 5 weeks of age defines a key immunological checkpoint. Sixty-two known genes are upregulated, and 18 are downregulated at this checkpoint in the NOD. The expression profiles are consistent with increased antibody production, antigen presentation, and cell proliferation associated with an active autoimmuneresponse. Seven of these genes map to confirmed diabetes susceptibility regions. Of these seven, three are excellent candidate genes not previously implicated in type 1 diabetes. Ten genes are differentially expressed between the NOD and congenic NOD at the immature stage (Hspa8, Hif1a, and several involved in cellular functions), while the other 70 genes exhibit expression differences during the mature (6-10 week) stage, suggesting that the expression differences of a small number of genes before onset of insulitis determine the disease progression.
UR - http://www.scopus.com/inward/record.url?scp=0842331569&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0842331569&partnerID=8YFLogxK
U2 - 10.2337/diabetes.53.2.366
DO - 10.2337/diabetes.53.2.366
M3 - Article
C2 - 14747287
AN - SCOPUS:0842331569
SN - 0012-1797
VL - 53
SP - 366
EP - 375
JO - Diabetes
JF - Diabetes
IS - 2
ER -